ConvaTec Healthcare Announces 2011 First Quarter Earnings Call

By Convatec, PRNE
Monday, June 13, 2011

SKILLMAN, New Jersey, June 14, 2011 -


- Analyst and
Investor Call To Be Held On June 17, 2011

ConvaTec Healthcare today announced that it will report its 2011
first quarter earnings on Friday, June 17, 2011. David Johnson, CEO
and George Kegler, CFO will host an analyst and investor call at
10:00 AM EDT live via telephone. Questions and answers will
follow.

To participate in the conference call within the U.S. and
Canada, dial (866) 701-0354.

To participate in the conference internationally, dial
+1-708-290-1340.

The conference ID is 74735682.

Participants should dial in 10 minutes prior to the start of the
call. The Company’s unaudited, 2011 First Quarter Report will be
filed on the Company’s website prior to the call at href="www.convateccorporate.com/">www.convateccorporate.com
under the Investor Relations tab.

A replay of the conference call will be available two hours
after the call. To access the conference call replay, please dial
(800) 642-1687 or +1-706- 645-9291 and reference conference ID
74735682. The replay will be available until July 8, 2011.

For more information, please contact
investorrelations@convatec.com

About ConvaTec

ConvaTec is a leading developer and marketer of innovative
medical technologies that have helped improve the lives of millions
of people worldwide. With four key focus areas - Ostomy Care, Wound
Therapeutics, Continence and Critical Care, and Infusion Devices -
ConvaTec products support healthcare professionals from the
hospital to the community health setting. For more information,
please visit href="www.convatec.com/">www.convatec.com.


    Investor Relations:
    Tim Winston
    VP, Treasurer
    ConvaTec
    investorrelations@convatec.com

    Media Relations:
    Nimisha Savani
    VP, Corporate Affairs
    ConvaTec
    +1-908-904-2522
    mediarelations@convatec.com

.

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :